The Longevity Revolution: Big Pharma’s New Frontier Longevity is no longer some sci-fi pipe dream. Nowadays, it’s the hot new thing in drug development. Since 2024, we’ve seen a boom in scientific breakthroughs and regulatory shifts that have turned aging biology from an academic afterthought into boardroom buzz. The Numbers Game Let’s talk dollars and […]
Retail investing’s been quite the scene lately, folks, with everyday people makin’ moves that were once the domain of pros. This little seismic shift’s captured in a study called “Taking Sides on Return Predictability” by R. David McLean, Jeffrey Pontiff, and Christopher Reilly. Those brainiacs published their findings in The Journal of Financial Economics and, […]
Sure, here’s a New Yorker-style version of the article: The scene was set at the annual gathering in Omaha, the big Berkshire Hathaway shindig. Warren Buffett, the man who makes markets move, chatted up his latest long-term play: Japanese trading houses. This ain’t a short fling, folks; it’s a “super long-term” endeavor, he says. You […]
When it comes to fresh chatter for investors, The Leuthold Group has just dropped a conversation starter: the Leuthold Select Industries ETF, ticker symbol LST. Forget dining with your favorite city’s typical sector hype. This is a curated gourmet experience where industry groups, roughly 120, get all the spotlight. They’re handpicking these industries and betting […]
As a quintessential New Yorker might say, there’s a storm brewing in the financial district. The big shots are lining up to file crypto ETFs, just as Gary Gensler, the head honcho at the SEC, is packing his bags. Financial titans like Tidal Financial Group, ProShares, CoinShares and VanEck are jumping in, sensing the winds […]
